Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration

Endocrinology

Volumn 149, Issue 11, 2008, Pages 5713-5723

  Ogita, Mami ^a   Rached, Marie Therese ^a   Dworakowski, Elzbieta ^a   Bilezikian, John P ^a   Kousteni, Stavroula ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AXIN; BONE MORPHOGENETIC PROTEIN 2; DEXAMETHASONE; ESTRADIOL; ESTROGEN; ETOPOSIDE; OSTEOCALCIN; PARATHYROID HORMONE[1-34]; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HORMONAL REGULATION; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STEM CELL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DRUG ADMINISTRATION SCHEDULE; ESTROGENS; GONADAL STEROID HORMONES; MICE; MICE, INBRED C57BL; OSTEOBLASTS; PARATHYROID HORMONE; PERIODICITY; PERIOSTEUM; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 54349084787     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0369     Document Type: Article

References (57)

1. Seeman E 2003 The structural and biomechanical basis of the gain and loss of bone strength in women and men. Endocrinol Metab Clin North Am 32:25-38
2. Seeman E 2001 Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576-4584
3. Orwoll ES 2003 Toward an expanded understanding of the role of the periosteum in skeletal health. J Bone Miner Res 18:949-954
4. Carter DR, Beaupré GS 2001 Skeletal function and form: mechanobiology of skeletal development. Cambridge, UK: Cambridge University Press
5. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
6. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409
7. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han K, DiGregorio G, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
8. Kousteni S, Han L, Chen J-R, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
9. Chen JR, Plotkin LI, Aguirre JI, Han L, Jilka RL, Kousteni S, Bellido T, Manolagas SC 2005 Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 280:4632-4638
10. Turner RT, Hannon KS, Demers LM, Buchanan J, Bell NH 1989 Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 4:557-563
11. Coxam V, Bowman BM, Mecham M, Roth CM, Miller MA, Miller SC 1996 Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats. Bone 19:107-114
12. Gunness M, Orwoll E 1995 Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats. J Bone Miner Res 10:1735-1744
13. Lea C, Kendall N, Flanagan AM 1996 Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats. Calcif Tissue Int 58:268-272
14. Kim BT, Mosekilde L, Duan Y, Zhang XZ, Tornvig L, Thomsen JS, Seeman E 2003 The structural and hormonal basis of sex differences in peak appendicular bone strength in rats. J Bone Miner Res 18:150-155
15. Seeman E 2002 Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850
16. Beck TJ, Ruff CB, Scott Jr WW, Plato CC, Tobin JD, Quan CA 1992 Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif Tissue Int 50:24-29
17. Dempster DW, Cosman F, Parisien M, Shen V 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709
18. Hodsman AB, Fraher LJ, Watson PH 1998 Parathyroid hormone: the clinical experience and prospects. In: Whitfield JF, Morley P, eds. Anabolic treatments for osteoporosis. 1st ed. Boca Raton, FL: CRC Press; 83-108
19. Bilezikian JP, Rubin MR, Finkelstein JS 2005 Parathyroid hormone as an anabolic therapy for women and men. J Endocrinol Invest 28:41-49
20. Rubin MR, Cosman F, Lindsay R, Bilezikian JP 2002 The anabolic effects of parathyroid hormone. Osteoporos Int 13:267-277
21. Jilka RL 2007 Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434-1446
22. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853
23. Rehman Q, Lang TF, Arnaud CD, Modin GW, Lane NE 2003 Daily treatment with parathyroid hormone is associated with an increase in vertebral crosssectional area in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 14:77-81
24. Hirano T, Burr DB, Cain RL, Hock JM 2000 Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34). Calcif Tissue Int 66:456-460
25. Zhou H, Shen V, Dempster DW, Lindsay R 2001 Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16:1300-1307
26. Parfitt AM 2002 Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741-1743
27. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446
28. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50259-50272
29. Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Valasek KM, Ducy P, Geiser AG 2003 Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol 17:423-435
30. Miao D, Tong XK, Chan GK, Panda D, McPherson PS, Goltzman D 2001 Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 276:32204-32213
31. Locklin RM, Khosla S, Turner RT, Riggs BL 2003 Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-190
32. Bord S, Horner A, Beavan S, Compston J 2001 Estrogen receptors α and β are differentially expressed in developing human bone. J Clin Endocrinol Metab 86:2309-2314
33. Kasperk C, Helmboldt A, Borcsok I, Heuthe S, Cloos O, Niethard F, Ziegler R 1997 Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif Tissue Int 61:464-473
34. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A 1999 Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J Bone Miner Res 14:1239-1249
35. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S 2005 Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280:41342-41351
36. Kousteni S, Chen J-R, Bellido T, Han L, Ali AA, O'Brien C, Plotkin LI, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfit AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
37. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A 1997 Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970
38. Westendorf JJ, Kahler RA, Schroeder TM 2004 Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39
39. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241
40. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC 2007 Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 27:1516-1530
41. Gallagher AC, Chambers TJ, Tobias JH 1996 Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats. Am J Physiol Endocrinol Metab 270:E407-E412
42. Tobias JH, Gallagher A, Chambers TJ 1994 5α- Dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats. Am J Physiol Endocrinol Metab 267:E853-E859
43. Bellido T, Plotkin LI, O'Brien CA, Manolagas SC, Jilka RL 2002 PTH-mediated control of proteasome-mediated degradation of Runx2/Cbfa1: a pivotal determinant of the longevity of PTH-initiated anti-apoptosis signaling in osteoblastic cells. J Bone Miner Res 17:S128
44. Wlodarski KH 1989 Normal and heterotopic periosteum. Clin Orthop Relat Res 241:265-277
45. Uchida A, Kikuchi T, Shimomura Y 1988 Osteogenic capacity of cultured human periosteal cells. Acta Orthop Scand 59:29-33
46. Breitbart AS, Grande DA, Kessler R, Ryaby JT, Fitzsimmons RJ, Grant RT 1998 Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast Reconstr Surg 101:567-574
47. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O'Keefe RJ, Guldberg RE 2005 Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20:2124-2137
48. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC 2005 Interaction of nuclear receptors with Wnt/β-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26:898-915
49. Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O'Brien CA, Manolagas SC, Jilka RL 2005 Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577-4583
50. Keller H, Kneissel M 2005 SOST is a target gene for PTH in bone. Bone 37:148-158
51. Bodine PVN, Kharode YP, Seestaller-Wehr L, Green. P, Milligan C, Bex FJ 2007 The bone anabolic effects of parathyroid hormone (PTH) are blunted by deletion of the Wnt antagonist secreted frizzled-related protein (sFRP)-1. J Cell Physiol 210:352-357
52. Guo J, Schipani E, Liu M, Bringhurst FR, Kronenberg HM 2005 Suppression of Dkk1 is not essential for PTH-mediated activation of canonical Wnt signaling in bone. J Bone Miner Res 20(Suppl 1):p S2 (Abstract)
53. Li X, Liu H, Qin L, Tamasi J, Bergenstock M, Shapses S, Feyen JH, Notterman DA, Partridge NC 2007 Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem 282:33086-33097
54. Onyia JE, Bidwell J, Herring J, Hulman J, Hock JM 1995 In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17:479-484
55. Qin L, Li X, Ko JK, Partridge NC 2005 Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase. J Biol Chem 280:3104-3111
56. Wang YH, Liu Y, Rowe DW 2007 Effects of transient PTH on early proliferation, apoptosis, and subsequent differentiation of osteoblast in primary osteoblast cultures. Am J Physiol Endocrinol Metab 292:E594-E603
57. Balena R, Shih M-S, Parfitt AM 1992 Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women. J Bone Miner Res 7:1475-1482